OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 124 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $751,000 | +622.1% | 95,900 | +458.9% | 0.00% | +300.0% |
Q4 2014 | $104,000 | -50.7% | 17,159 | -47.0% | 0.00% | -50.0% |
Q1 2014 | $211,000 | +142.5% | 32,398 | +110.4% | 0.00% | +100.0% |
Q4 2013 | $87,000 | -70.3% | 15,400 | -69.3% | 0.00% | -66.7% |
Q2 2013 | $293,000 | – | 50,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 1,250,000 | $8,125,000 | 5.71% |
Rock Springs Capital Management LP | 830,000 | $5,395,000 | 1.24% |
First Light Asset Management, LLC | 195,359 | $1,270,000 | 0.90% |
Palo Alto Investors LP | 3,338,048 | $21,698,000 | 0.90% |
Rhenman & Partners Asset Management AB | 329,199 | $2,140,000 | 0.64% |
NEA Management Company, LLC | 1,935,300 | $12,579,000 | 0.62% |
PFM Health Sciences, LP | 5,129,129 | $33,339,000 | 0.60% |
Sivik Global Healthcare LLC | 124,145 | $807,000 | 0.50% |
QVT Financial LP | 1,322,729 | $8,598,000 | 0.49% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 433,657 | $2,819,000 | 0.41% |